Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

68
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
68
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

187
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
187
Human Genetics01:28

Human Genetics

569
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
569

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tobacco and Nicotine Dependence Vulnerability as a Function of Dopaminergic Dysregulation: Proposing a Novel Strategy to Promote Neurotransmitter Homeostasis.

Current neuropharmacology·2026
Same author

Spectral EEG-guided adaptive neuromodulation for social anxiety disorder, performance-only subtype: a case report.

Frontiers in psychiatry·2026
Same author

Opioid-Induced Nodding-Not a Nice Nap.

Acta scientific neurology·2026
Same author

Corrigendum to "Selective upregulation of fatty acid-binding protein 5 within the basolateral amygdala blunts stress-induced reinstatement of cocaine-seeking behavior in mice" [Neurosci. Lett. 878 (2026) 138558].

Neuroscience letters·2026
Same author

Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?

British journal of healthcare and medical research·2026
Same author

Sustained Attention Instability as a Cognitive Biomarker in Chronic Spine Pain: A 90-second Visual Attention Test.

European journal of pain (London, England)·2026

Related Experiment Video

Updated: Jul 2, 2025

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
13:11

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain

Published on: July 12, 2012

18.8K

Chronic Methylphenidate Effects on Brain Gene Expression: An Exploratory Review.

Shannon Rae Klein1, Kenneth Blum2, Mark S Gold3

  • 1Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.

Psychology Research and Behavior Management
|February 21, 2024
PubMed
Summary

Methylphenidate (MP), used for ADHD and performance enhancement, broadly potentiates genes in the brain. This leads to region-specific neuronal alterations, affecting synaptic plasticity and transmission.

Keywords:
addictiongene expressionmethylphenidatemonoamine neurotransmitters postsynaptic density proteinsreward deficiency syndromesubstance abuse

More Related Videos

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.2K
Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1
11:19

Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1

Published on: September 26, 2015

8.0K

Related Experiment Videos

Last Updated: Jul 2, 2025

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
13:11

Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain

Published on: July 12, 2012

18.8K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.2K
Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1
11:19

Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1

Published on: September 26, 2015

8.0K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Methylphenidate (MP) is a widely prescribed psychostimulant for Attention Deficit Hyperactivity Disorder (ADHD).
  • MP is also used illicitly for cognitive and academic performance enhancement.
  • Previous studies have explored MP's impact on behavior, cognition, and neurochemistry.

Purpose of the Study:

  • To review the established uses of Methylphenidate (MP).
  • To explore the effects of MP exposure on gene expression within the brain.
  • To correlate observed gene expression changes with neuronal alterations and behavioral outcomes.

Main Methods:

  • This study is an exploratory review of existing literature.
  • It synthesizes findings on MP's effects on gene expression in the brain.
  • Analysis focuses on region-specific gene expression patterns following MP exposure.

Main Results:

  • MP exposure results in widespread, region-specific potentiation of gene expression in the brain.
  • Observed gene expression changes are linked to neuronal alterations, including synaptic plasticity and transmission.
  • Monoamine neurotransmitter and postsynaptic density protein genes commonly show potentiated expression after MP exposure.

Conclusions:

  • Methylphenidate significantly influences brain gene expression in a localized manner.
  • These molecular changes underlie MP's effects on neuronal function and observable behaviors.
  • Understanding MP's gene expression profile is crucial for both therapeutic and performance-enhancement contexts.